ATAI Life Sciences
ATAI
ATAI
104 hedge funds and large institutions have $31.1M invested in ATAI Life Sciences in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 27 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 116 → 104 (-12)
42% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 24
53% less capital invested
Capital invested by funds: $66.6M → $31.1M (-$35.5M)
Holders
104
Holding in Top 10
1
Calls
$770K
Puts
$109K
Top Buyers
| 1 | +$1.04M | |
| 2 | +$887K | |
| 3 | +$652K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$434K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$430K |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$4.36M | |
| 3 | -$3.51M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.26M |
| 5 |
Millennium Management
New York
|
-$917K |